Stockreport

Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026

Disc Medicine, Inc.  (IRON) 
PDF Bitopertin was awarded the Commissioner’s National Priority Review Voucher (CNPV) and NDA is currently under FDA reviewUpdated data from the Phase 2 study of DISC-0974 i [Read more]